Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Literature
1.
Hübner T, Nickel T, Steinbeck G, Massberg S, Schramm R, Reichart B, Hagl C, Kiwi A, Weis M (2015) A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list. Clin Res Cardiol [Epub ahead of print]
2.
Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M, SURVIVE Investigators (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 297(17):1883–1891CrossRefPubMed
3.
Aranda JM Jr, Schofield RS, Pauly DF, Cleeton TS, Walker TC, Monroe VS Jr, Leach D, Lopez LM, Hill JA (2003) Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J 145(2):324–329CrossRefPubMed
4.
Antila S, Sundberg S, Lehtonen LA (2007) Clinical pharmacology of levosimendan. Clin Pharmacokinet 46(7):535–552CrossRefPubMed
5.
Lehtonen LA, Antila S, Pentikäinen PJ (2004) Pharmacokinetics and pharmacodynamics of intravenous inotropic agents. Clin Pharmacokinet 43(3):187–203CrossRefPubMed
6.
Thackray S, Easthaugh J, Freemantle N, Cleland JG (2002) The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: a meta-regression analysis. Eur J Heart Fail 4(4):515–529CrossRefPubMed
7.
Dixon JR Jr (1998) The international conference on harmonization good clinical practice guideline. Qual Assur 6(2):65–74PubMed
8.
Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV (2007) Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153(1):98–104CrossRefPubMed
9.
Levine BS (2000) Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure. J Cardiovasc Nurs 14(4):76–93CrossRefPubMed
10.
Felker GM, O’Connor CM (2001) Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 142(3):393–401CrossRefPubMed
11.
Parissis JT, Adamopoulos S, Farmakis D et al (2006) Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Heart 92:1768–1772PubMedCentralCrossRefPubMed
Metadata
Title
Intermittent inotrope therapy: evidence or belief?
Authors
Stephan Ensminger
Uwe Schulz
P. Christian Schulze
Friedrich-Wilhelm Mohr
Jan Gummert
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 11/2015
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0903-7

Other articles of this Issue 11/2015

Clinical Research in Cardiology 11/2015 Go to the issue

Original Paper

Catheter ablation of pediatric AV nodal reentrant tachycardia: results in small children

Original Paper

Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up

Original Paper

Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR

Original Paper

The relationship of QRS morphology with cardiac structure and function in patients with heart failure

Original Paper

Diastolic pressure–volume quotient (DPVQ) as a novel echocardiographic index for estimation of LV stiffness in HFpEF

Original Paper

Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits